Recombinant collagen creams heat up: New dividends from shifting channels

Recombinant collagen creams heat up has been gaining momentum. Data shows that in Q2, top-brand concentration rose to 15.8%, and industry attention is clearly rising. This piece breaks down new dividends from shifting channels using public information and platform data.

Competitively, moves by leaders such as HBN are a bellwether. Performance in Guangzhou deserves particular attention, as shifts in channel and audience structure are reshaping growth logic.

Two signals stand out from HBN’s latest moves: resources keep concentrating at the top, while incremental markets like Guangzhou gain bargaining power.

For practitioners, three directions follow: differentiate product and content back to R&D and supply chain; build localisation capability for markets such as Guangzhou; and treat compliance and data capability as the new moat.

Bottom line: recombinant collagen creams heat up is moving from concept to execution — new dividends from shifting channels. Brands should review strategy before Q2 and prioritise channels and segments with higher certainty.

Related